IDEXX LABORATORIES INC /DE (IDXX) FY2025 Q1 P&L / Income Statement
2025-01-01 to 2025-03-31
Revenue by Business Segment
2025-01-01 to 2025-03-31
Swipe to see the full flow
Chart details
IDEXX LABORATORIES INC /DE (IDXX) FY2025 Q1 P&L / Income Statement
Income statement for 2025-01-01 through 2025-03-31. View: Business segment. Revenue uses this breakdown; costs and expenses retain the consolidated categories.
- Total revenue
- 998,427,000 US dollars
- Total cost of revenue
- 375,048,000 US dollars
- Gross profit
- 623,379,000 US dollars
- Total operating expense
- 306,845,000 US dollars
- Income from operations
- 316,534,000 US dollars
- Other income (expense), net (calculated)
- negative 6,450,000 US dollars
- Income before provision for income taxes
- 310,084,000 US dollars
- Provision for income taxes
- 67,407,000 US dollars
- Net income
- 242,677,000 US dollars
- CAG segment revenue
- 919,836,000 US dollars
- Water segment revenue
- 45,321,000 US dollars
- LPD segment revenue
- 28,596,000 US dollars
- Research and development
- 59,061,000 US dollars
- Sales and marketing
- 156,223,000 US dollars
- General and administrative
- 91,561,000 US dollars
- Revenue before reconciliation (calculated)
- 993,753,000 US dollars. Sum of the reported revenue categories before the separately reported reconciliation.
- Other segment revenue
- 4,674,000 US dollars. Reported reconciliation to consolidated revenue.
Chart connections
- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
- Reported revenue categories plus the separately reported signed reconciliation equals consolidated revenue.

Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG
Gross margin
62.4%
Gross profit / revenue
Operating margin
31.7%
Operating profit / revenue
Cash conversion
98.1%
Operating cash / net income, same period
Product waitlist
Health Check and Teardown for your own company
A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!
